Cited by 3Vitamin C and Antioxidants ResearchAntioxidant Activity and Oxidative StressGastrointestinal motility and disorders

Effects of Ester‐C ® and Ascorbic Acid on Gastrointestinal Outcomes: A Randomized, Double‐Blind Trial

Ye, Qian, Combs, Maile, Mitmesser, Susan·2015·The FASEB Journal

Abstract

Background Optimum vitamin C intake is not always attainable solely via food consumption, therefore supplementation may be desirable. However, vitamin C supplementation is not without notable gastrointestinal discomfort resulting from its acidic nature, which may affect overall quality of life. Objective To compare the effects of Ester‐C ® (EC) and Ascorbic Acid (AA) on gastrointestinal symptoms and quality of life in subjects with acid‐sensitivity. Methods In this double‐blind, cross‐over study, 50 healthy adults with acid‐sensitivity were randomized to receive vitamin C (1000 mg for Day 1‐5, 2000 mg for Day 6‐10) provided by either AA or EC. Gastrointestinal side effects as measured by Gastrointestinal Symptom Rating Scale (GSRS) and the associated changes in quality of life as measured by Medical Outcomes Short Form‐36 (SF‐36) were assessed. Results An intention‐to‐treat analysis was conducted on 50 subjects (11 males, 39 females). After ten days of treatment, AA resulted in significant worsening of Abdominal pain (p=0.02), Diarrhea (p=0.047), and total GSRS score (p=0.019), while there were no significant changes in EC group. The Role Physical and Bodily Pain scores were significantly better in EC group compared to AA group over the ten‐day period (p = 0.004 and 0.008, respectively). Conclusion Ester‐C ® is better tolerated than Ascorbic Acid in individuals with acid‐sensitivity.

Integrity signals

Registry

Crossref · 10.1096/fasebj.29.1_supplement.920.8

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In participants with acid sensitivity using higher dosages (1000 mg daily day 1-5, 2000 mg daily day 6-10), no significant changes were observed in gastrointestinal symptoms of those taking Calcium ascorbate EC.

    “Finally, even when using higher dosages and in participants with acid sensitivity (1000 mg daily for day 1–5, 2000 mg daily for day 6–10), no significant changes were observed in the gastrointestinal symptoms of those taking Calcium ascorbate EC, whereas ascorbic acid was associated with increases in abdominal pain (p = 0.02), diarrhea (p = 0.047), and worsening of the overall Gastrointestinal Sym”
  • In the same study, ascorbic acid was associated with increases in abdominal pain (p=0.02), diarrhea (p=0.047), and worsening of overall Gastrointestinal Symptom Rating Scale score (p=0.019).

    “Finally, even when using higher dosages and in participants with acid sensitivity (1000 mg daily for day 1–5, 2000 mg daily for day 6–10), no significant changes were observed in the gastrointestinal symptoms of those taking Calcium ascorbate EC, whereas ascorbic acid was associated with increases in abdominal pain (p = 0.02), diarrhea (p = 0.047), and worsening of the overall Gastrointestinal Sym”
  • Over the 10-day period, Role Physical and Bodily Pain scores were significantly improved in the Calcium ascorbate EC group compared to the ascorbic acid group (p=0.004 and p=0.008).

    “Additionally, over the 10-day period, the Role Physical and Bodily Pain scores were significantly improved in the Calcium ascorbate EC group compared to the ascorbic acid group (p = 0.004 and p = 0.008, respectively).”

Cited by

Sorted by citations

Authors
Ye, Q., Combs, M., & Mitmesser, S.
Affiliations
Department of Nutrition Research NBTY, Inc Ronkonkoma NY United States
Venue
The FASEB Journal
Publisher
Wiley
Published
2015-04
Volume
29
Issue
S1
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W1010845280
Cited by
3
References
0
Citations by year
2025: 1 · 2024: 1 · 2016: 1
FWCI
0.32
Type
journal article
Language
en
Open access
closed
Locations
The FASEB Journal (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
  • Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
vitamin C, vitamin C supplementation, gastrointestinal adverse effects, acid sensitivity, abdominal pain, diarrhea, quality of life, tolerability, Gastrointestinal Symptom Rating Scale, SF-36

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review